Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 12:30 PM
Ignite Modification Date:
2025-12-25 @ 12:09 PM
NCT ID:
NCT02408861
Pre Assignment Details:
Participants with histologically confirmed solid malignancy and HIV infection. Solid malignancy must be metastatic or unresectable and standard curative or palliative measures are nonexistent or no longer effective. Uncontrolled Kaposi sarcoma is permitted. Participants with relapsed refractory HIV-associated classical Hodgkin lymphoma (HIV-cHL) as a separate cohort.
Recruitment Details:
Enrollment started in October 2015 and ended June 2023 across 7 different cohorts, and 17 study sites.
Study:
NCT02408861
Study Brief:
Results Section:
NCT02408861